Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Global Alliance in Soil Clean-Up and Seed Yields

By HospiMedica staff writers
Posted on 31 Aug 2001
An alliance to increase the growth rate of grasses and other plants and remediate soil contaminated by agrochemicals has been formed by U.S. More...
and Russian scientists. The Russian scientists are from BioChimmash, a former weapons development center, Lomonosov Moscow State University, and the Russian State Institute for Gas and Oil.
The U.S. scientists are from Dye Seed Ranch (Pomeroy, WA, USA), a seed processing company, and the Pacific Northwest National Laboratory (PNNL, Richland, WA, USA) of the U.S. Department of Energy (DOE).

The Russian scientists have developed a plant growth stimulator that is a mixture of fungi and bacteria, called Symbiont, because of the symbiotic relationship between microbes and the plant root in soil. Initial studies showed it increased the growth of grasses and many broad-leaf plants by 40% under controlled conditions. Symbiont may be able to shorten the current 18 months seed producers like Dye Seed wait after planting before harvesting their first crop. Scientists are planning a test of Symbiont with different soil types and moisture status.

"Rather than waiting 28 days for Kentucky Blue Grass seeds to germinate, that process may take only seven days with Symbiont,” said Steve Stilson, general manager of Dye Seed. The company processes and markets seed, primarily Kentucky Blue Grass. About 60% of the world's Kentucky Blue Grass is produced in the Pacific Northwest.

The Russian scientists have also developed microbes capable of remediating oil-contaminated fields, which may hold promise for industries looking for new methods to clean up agrochemicals. The microbes help break down the oil and restore the soil. Dye Seed may commercialize the oil remediation application or support further research into its potential.

The laboratory studies and subsequent verification tests that are performed at PNNL are being funded by the DOE's Initiatives for Proliferation Prevention Program (IPP), established in 1994 to create non-defense jobs for former Soviet weapons scientists by linking them with U.S. companies interested in commercializing their non-weapons technologies. "The preliminary lab results for these projects are very promising,” said Steve Stilson. "If these field tests show potential, it would be beyond my wildest dreams.”




Related Links:
PNNL

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.